These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25788051)

  • 1. Enhanced anticancer activity of 5-FU in combination with Bestatin: Evidence in human tumor-derived cell lines and an H22 tumor-bearing mouse.
    Li J; Wang X; Hou J; Huang Y; Zhang Y; Xu W
    Drug Discov Ther; 2015 Feb; 9(1):45-52. PubMed ID: 25788051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition.
    Sun ZP; Zhang J; Shi LH; Zhang XR; Duan Y; Xu WF; Dai G; Wang XJ
    Biomed Pharmacother; 2015 Dec; 76():65-72. PubMed ID: 26653552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary detection of the anti‑tumour activity of indoline‑2,3‑dione derivative DH‑12a targeting aminopeptidase N.
    Cui DX; Wang XJ; Zhang XR; Zhao TK; Guo XX; Liu SM; Wang B; Ma WQ; Gao ZQ
    Mol Med Rep; 2014 Nov; 10(5):2681-8. PubMed ID: 25216231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis.
    Dun J; Chen X; Gao H; Zhang Y; Zhang H; Zhang Y
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1672-81. PubMed ID: 25736303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BRCA2 gene is a potential molecular target during 5-fluorouracil therapy in human oral cancer cells.
    Nakagawa Y; Kajihara A; Takahashi A; Kondo N; Mori E; Kirita T; Ohnishi T
    Oncol Rep; 2014 May; 31(5):2001-6. PubMed ID: 24627042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
    Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
    Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
    Terauchi M; Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
    BMC Cancer; 2007 Jul; 7():140. PubMed ID: 17655775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.
    Yamashita M; Wada H; Eguchi H; Ogawa H; Yamada D; Noda T; Asaoka T; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
    Int J Oncol; 2016 Jul; 49(1):89-98. PubMed ID: 27121124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells.
    Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H
    Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antitumor activity of low-dose 5-fluorouracil by combination with Fuzheng-Yiliu granules in hepatoma 22 tumor-bearing mice.
    Cao Z; Liao L; Chen X; Lan L; Hu H; Liu Z; Chen L; Huang S; Du J
    Integr Cancer Ther; 2013 Mar; 12(2):174-81. PubMed ID: 22791308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.
    Ghosh S; Pal A; Ray M
    Biomed Pharmacother; 2019 Jun; 114():108855. PubMed ID: 31003140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13).
    Cui SX; Zhang HL; Xu WF; Qu XJ
    Eur J Pharmacol; 2014 Jul; 734():50-9. PubMed ID: 24726845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subcutaneous transplantation of microencapsulated Chinese hamster ovary (CHO) cells/pcDNA 3.1/mIL-12 and subcutaneous transplantation of microencapsulated CHO/pcDNA3.1/mIL-12 combined with 5-fluoro-uracil in treatment of tumor-burdened mice].
    Pan YL; Zheng S; Xiao ZX; Cao J; Yao HP
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):51-4. PubMed ID: 12757646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
    Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
    Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
    Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
    Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
    Cao J; Zang J; Kong X; Zhao C; Chen T; Ran Y; Dong H; Xu W; Zhang Y
    Bioorg Med Chem; 2019 Mar; 27(6):978-990. PubMed ID: 30737134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy.
    Jiang Y; Li X; Hou J; Huang Y; Wang X; Jia Y; Wang Q; Xu W; Zhang J; Zhang Y
    Eur J Med Chem; 2018 Jan; 143():334-347. PubMed ID: 29202398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
    Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
    Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.